APO Research
Talk to an analyst

APO RESEARCH · REPORT

Psychobiotic Supplements

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Psychobiotic Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025193 pages

Choose your research edition.

Industry ResearchPsychobiotic Supplements Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Psychobiotic Supplements Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Psychobiotic Supplements Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Psychobiotic Supplements Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Psychobiotic Supplements Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Psychobiotic Supplements market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Psychobiotic Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Psychobiotic Supplements include Life Extension, Lifted Naturals, NEURAXPHARM, Uplift Food Pty Ltd., Nutrimmun GmbH, InnovixLabs, Optibac Probiotics, Seraphina Therapeutics and SFI Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Psychobiotic Supplements market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Psychobiotic Supplements and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Psychobiotic Supplements sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Psychobiotic Supplements market size, projected growth trends, production technologies, key applications, and end-use industries.

Psychobiotic Supplements Segment by Company

Life Extension

Lifted Naturals

NEURAXPHARM

Uplift Food Pty Ltd.

Nutrimmun GmbH

InnovixLabs

Optibac Probiotics

Seraphina Therapeutics

SFI Health

Microbiome Labs

G1 NUTRITION

Psychobiotic Supplements Segment by Type

Capsules

Tablets

Other

Psychobiotic Supplements Segment by Application

Offline Sales

Online Sales

Psychobiotic Supplements Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psychobiotic Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Psychobiotic Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psychobiotic Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Psychobiotic Supplements market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Psychobiotic Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Psychobiotic Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Psychobiotic Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Psychobiotic Supplements Industry Trends Table 2. Psychobiotic Supplements Industry Drivers Table 3. Psychobiotic Supplements Industry Opportunities and Challenges Table 4. Psychobiotic Supplements Industry Restraints Table 5. Global Psychobiotic Supplements Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Psychobiotic Supplements Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Psychobiotic Supplements Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Psychobiotic Supplements Sales Market Share by Manufacturers Table 9. Global Psychobiotic Supplements Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Psychobiotic Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Psychobiotic Supplements Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Psychobiotic Supplements Manufacturers, Product Type & Application Table 13. Global Psychobiotic Supplements Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Psychobiotic Supplements by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Capsules Table 17. Major Manufacturers of Tablets Table 18. Major Manufacturers of Other Table 19. Global Psychobiotic Supplements Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Psychobiotic Supplements Sales by Type (2021-2026) & (k units) Table 21. Global Psychobiotic Supplements Sales by Type (2027-2032) & (k units) Table 22. Global Psychobiotic Supplements Sales Market Share by Type (2021-2026) Table 23. Global Psychobiotic Supplements Sales Market Share by Type (2027-2032) Table 24. Global Psychobiotic Supplements Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Psychobiotic Supplements Revenue by Type (2021-2026) & (k units) Table 26. Global Psychobiotic Supplements Revenue by Type (2027-2032) & (k units) Table 27. Global Psychobiotic Supplements Revenue Market Share by Type (2021-2026) Table 28. Global Psychobiotic Supplements Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Offline Sales Table 30. Major Manufacturers of Online Sales Table 31. Global Psychobiotic Supplements Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Psychobiotic Supplements Sales by Application (2021-2026) & (k units) Table 33. Global Psychobiotic Supplements Sales by Application (2027-2032) & (k units) Table 34. Global Psychobiotic Supplements Sales Market Share by Application (2021-2026) Table 35. Global Psychobiotic Supplements Sales Market Share by Application (2027-2032) Table 36. Global Psychobiotic Supplements Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Psychobiotic Supplements Revenue by Application (2021-2026) & (k units) Table 38. Global Psychobiotic Supplements Revenue by Application (2027-2032) & (k units) Table 39. Global Psychobiotic Supplements Revenue Market Share by Application (2021-2026) Table 40. Global Psychobiotic Supplements Revenue Market Share by Application (2027-2032) Table 41. Global Psychobiotic Supplements Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Psychobiotic Supplements Sales by Region (2021-2026) & (k units) Table 43. Global Psychobiotic Supplements Sales Market Share by Region (2021-2026) Table 44. Global Psychobiotic Supplements Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Psychobiotic Supplements Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 48. North America Psychobiotic Supplements Sales by Country (2027-2032) & (k units) Table 49. Europe Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 51. Europe Psychobiotic Supplements Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Psychobiotic Supplements Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Psychobiotic Supplements Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Psychobiotic Supplements Sales by Country (2027-2032) & (k units) Table 58. Global Psychobiotic Supplements Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Psychobiotic Supplements Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Psychobiotic Supplements Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Psychobiotic Supplements Revenue Market Share by Region (2021-2026) Table 62. Global Psychobiotic Supplements Revenue Market Share by Region (2027-2032) Table 63. Life Extension Company Information Table 64. Life Extension Business Overview Table 65. Life Extension Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Life Extension Psychobiotic Supplements Product Portfolio Table 67. Life Extension Recent Development Table 68. Lifted Naturals Company Information Table 69. Lifted Naturals Business Overview Table 70. Lifted Naturals Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Lifted Naturals Psychobiotic Supplements Product Portfolio Table 72. Lifted Naturals Recent Development Table 73. NEURAXPHARM Company Information Table 74. NEURAXPHARM Business Overview Table 75. NEURAXPHARM Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. NEURAXPHARM Psychobiotic Supplements Product Portfolio Table 77. NEURAXPHARM Recent Development Table 78. Uplift Food Pty Ltd. Company Information Table 79. Uplift Food Pty Ltd. Business Overview Table 80. Uplift Food Pty Ltd. Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio Table 82. Uplift Food Pty Ltd. Recent Development Table 83. Nutrimmun GmbH Company Information Table 84. Nutrimmun GmbH Business Overview Table 85. Nutrimmun GmbH Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Nutrimmun GmbH Psychobiotic Supplements Product Portfolio Table 87. Nutrimmun GmbH Recent Development Table 88. InnovixLabs Company Information Table 89. InnovixLabs Business Overview Table 90. InnovixLabs Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. InnovixLabs Psychobiotic Supplements Product Portfolio Table 92. InnovixLabs Recent Development Table 93. Optibac Probiotics Company Information Table 94. Optibac Probiotics Business Overview Table 95. Optibac Probiotics Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Optibac Probiotics Psychobiotic Supplements Product Portfolio Table 97. Optibac Probiotics Recent Development Table 98. Seraphina Therapeutics Company Information Table 99. Seraphina Therapeutics Business Overview Table 100. Seraphina Therapeutics Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Seraphina Therapeutics Psychobiotic Supplements Product Portfolio Table 102. Seraphina Therapeutics Recent Development Table 103. SFI Health Company Information Table 104. SFI Health Business Overview Table 105. SFI Health Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. SFI Health Psychobiotic Supplements Product Portfolio Table 107. SFI Health Recent Development Table 108. Microbiome Labs Company Information Table 109. Microbiome Labs Business Overview Table 110. Microbiome Labs Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Microbiome Labs Psychobiotic Supplements Product Portfolio Table 112. Microbiome Labs Recent Development Table 113. G1 NUTRITION Company Information Table 114. G1 NUTRITION Business Overview Table 115. G1 NUTRITION Psychobiotic Supplements Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. G1 NUTRITION Psychobiotic Supplements Product Portfolio Table 117. G1 NUTRITION Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Psychobiotic Supplements Distributors List Table 121. Psychobiotic Supplements Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Psychobiotic Supplements Product Image Figure 2. Global Psychobiotic Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Psychobiotic Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Psychobiotic Supplements Sales (2021-2032) & (k units) Figure 5. Global Psychobiotic Supplements Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Psychobiotic Supplements Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Capsules Image Figure 9. Tablets Image Figure 10. Other Image Figure 11. Global Psychobiotic Supplements Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Psychobiotic Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Psychobiotic Supplements Sales Market Share by Type (2021-2032) Figure 14. Global Psychobiotic Supplements Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Psychobiotic Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Psychobiotic Supplements Revenue Market Share by Type (2021-2032) Figure 17. Offline Sales Image Figure 18. Online Sales Image Figure 19. Global Psychobiotic Supplements Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Psychobiotic Supplements Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Psychobiotic Supplements Sales Market Share by Application (2021-2032) Figure 22. Global Psychobiotic Supplements Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Psychobiotic Supplements Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Psychobiotic Supplements Revenue Market Share by Application (2021-2032) Figure 25. North America Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Psychobiotic Supplements Sales Market Share by Country (2021-2032) Figure 27. U.S. Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Psychobiotic Supplements Sales Market Share by Country (2021-2032) Figure 32. Germany Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Psychobiotic Supplements Sales Market Share by Country (2021-2032) Figure 39. China Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Psychobiotic Supplements Sales Market Share by Country (2021-2032) Figure 47. Brazil Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Psychobiotic Supplements Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Psychobiotic Supplements Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Psychobiotic Supplements Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Psychobiotic Supplements Revenue (2021-2032) & (US$ Million) Figure 58. North America Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Psychobiotic Supplements Revenue (2021-2032) & (US$ Million) Figure 60. Europe Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Psychobiotic Supplements Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Psychobiotic Supplements Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Psychobiotic Supplements Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Psychobiotic Supplements Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Tablets
  • Other
Applications
  • Offline Sales
  • Online Sales
Companies covered
  • Life Extension
  • Lifted Naturals
  • NEURAXPHARM
  • Uplift Food Pty Ltd.
  • Nutrimmun GmbH
  • InnovixLabs
  • Optibac Probiotics
  • Seraphina Therapeutics
  • SFI Health
  • Microbiome Labs
  • G1 NUTRITION

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Psychobiotic Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Psychobiotic Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Psychobiotic Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Psychobiotic Supplements Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Psychobiotic Supplements Market Dynamics
  1. 2.1 Psychobiotic Supplements Industry Trends
  2. 2.2 Psychobiotic Supplements Industry Drivers
  3. 2.3 Psychobiotic Supplements Industry Opportunities and Challenges
  4. 2.4 Psychobiotic Supplements Industry Restraints
3 Psychobiotic Supplements Market by Manufacturers
  1. 3.1 Global Psychobiotic Supplements Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Psychobiotic Supplements Sales by Manufacturers (2021-2026)
  3. 3.3 Global Psychobiotic Supplements Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Psychobiotic Supplements Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Psychobiotic Supplements Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Psychobiotic Supplements Manufacturers, Product Type & Application
  7. 3.7 Global Psychobiotic Supplements Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Psychobiotic Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Psychobiotic Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Psychobiotic Supplements Tier 1, Tier 2, and Tier 3
4 Psychobiotic Supplements Market by Type
  1. 4.1 Psychobiotic Supplements Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Tablets
  4. 4.1.3 Other
  5. 4.2 Global Psychobiotic Supplements Sales by Type
  6. 4.2.1 Global Psychobiotic Supplements Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Psychobiotic Supplements Sales by Type (2021-2032)
  8. 4.2.3 Global Psychobiotic Supplements Sales Market Share by Type (2021-2032)
  9. 4.3 Global Psychobiotic Supplements Revenue by Type
  10. 4.3.1 Global Psychobiotic Supplements Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Psychobiotic Supplements Revenue by Type (2021-2032)
  12. 4.3.3 Global Psychobiotic Supplements Revenue Market Share by Type (2021-2032)
5 Psychobiotic Supplements Market by Application
  1. 5.1 Psychobiotic Supplements Application Introduction
  2. 5.1.1 Offline Sales
  3. 5.1.2 Online Sales
  4. 5.2 Global Psychobiotic Supplements Sales by Application
  5. 5.2.1 Global Psychobiotic Supplements Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Psychobiotic Supplements Sales by Application (2021-2032)
  7. 5.2.3 Global Psychobiotic Supplements Sales Market Share by Application (2021-2032)
  8. 5.3 Global Psychobiotic Supplements Revenue by Application
  9. 5.3.1 Global Psychobiotic Supplements Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Psychobiotic Supplements Revenue by Application (2021-2032)
  11. 5.3.3 Global Psychobiotic Supplements Revenue Market Share by Application (2021-2032)
6 Global Psychobiotic Supplements Sales by Region
  1. 6.1 Global Psychobiotic Supplements Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Psychobiotic Supplements Sales by Region (2021-2032)
  3. 6.2.1 Global Psychobiotic Supplements Sales by Region (2021-2026)
  4. 6.2.2 Global Psychobiotic Supplements Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Psychobiotic Supplements Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Psychobiotic Supplements Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Psychobiotic Supplements Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Psychobiotic Supplements Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Psychobiotic Supplements Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Psychobiotic Supplements Revenue by Region
  1. 7.1 Global Psychobiotic Supplements Revenue by Region
  2. 7.1.1 Global Psychobiotic Supplements Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Psychobiotic Supplements Revenue by Region (2021-2026)
  4. 7.1.3 Global Psychobiotic Supplements Revenue by Region (2027-2032)
  5. 7.1.4 Global Psychobiotic Supplements Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Psychobiotic Supplements Revenue (2021-2032)
  8. 7.2.2 North America Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Psychobiotic Supplements Revenue (2021-2032)
  11. 7.3.2 Europe Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Psychobiotic Supplements Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Psychobiotic Supplements Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Psychobiotic Supplements Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Life Extension
  2. 8.1.1 Life Extension Company Information
  3. 8.1.2 Life Extension Business Overview
  4. 8.1.3 Life Extension Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Life Extension Psychobiotic Supplements Product Portfolio
  6. 8.1.5 Life Extension Recent Developments
  7. 8.2 Lifted Naturals
  8. 8.2.1 Lifted Naturals Company Information
  9. 8.2.2 Lifted Naturals Business Overview
  10. 8.2.3 Lifted Naturals Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lifted Naturals Psychobiotic Supplements Product Portfolio
  12. 8.2.5 Lifted Naturals Recent Developments
  13. 8.3 NEURAXPHARM
  14. 8.3.1 NEURAXPHARM Company Information
  15. 8.3.2 NEURAXPHARM Business Overview
  16. 8.3.3 NEURAXPHARM Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NEURAXPHARM Psychobiotic Supplements Product Portfolio
  18. 8.3.5 NEURAXPHARM Recent Developments
  19. 8.4 Uplift Food Pty Ltd.
  20. 8.4.1 Uplift Food Pty Ltd. Company Information
  21. 8.4.2 Uplift Food Pty Ltd. Business Overview
  22. 8.4.3 Uplift Food Pty Ltd. Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Uplift Food Pty Ltd. Psychobiotic Supplements Product Portfolio
  24. 8.4.5 Uplift Food Pty Ltd. Recent Developments
  25. 8.5 Nutrimmun GmbH
  26. 8.5.1 Nutrimmun GmbH Company Information
  27. 8.5.2 Nutrimmun GmbH Business Overview
  28. 8.5.3 Nutrimmun GmbH Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nutrimmun GmbH Psychobiotic Supplements Product Portfolio
  30. 8.5.5 Nutrimmun GmbH Recent Developments
  31. 8.6 InnovixLabs
  32. 8.6.1 InnovixLabs Company Information
  33. 8.6.2 InnovixLabs Business Overview
  34. 8.6.3 InnovixLabs Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 InnovixLabs Psychobiotic Supplements Product Portfolio
  36. 8.6.5 InnovixLabs Recent Developments
  37. 8.7 Optibac Probiotics
  38. 8.7.1 Optibac Probiotics Company Information
  39. 8.7.2 Optibac Probiotics Business Overview
  40. 8.7.3 Optibac Probiotics Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Optibac Probiotics Psychobiotic Supplements Product Portfolio
  42. 8.7.5 Optibac Probiotics Recent Developments
  43. 8.8 Seraphina Therapeutics
  44. 8.8.1 Seraphina Therapeutics Company Information
  45. 8.8.2 Seraphina Therapeutics Business Overview
  46. 8.8.3 Seraphina Therapeutics Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Seraphina Therapeutics Psychobiotic Supplements Product Portfolio
  48. 8.8.5 Seraphina Therapeutics Recent Developments
  49. 8.9 SFI Health
  50. 8.9.1 SFI Health Company Information
  51. 8.9.2 SFI Health Business Overview
  52. 8.9.3 SFI Health Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SFI Health Psychobiotic Supplements Product Portfolio
  54. 8.9.5 SFI Health Recent Developments
  55. 8.10 Microbiome Labs
  56. 8.10.1 Microbiome Labs Company Information
  57. 8.10.2 Microbiome Labs Business Overview
  58. 8.10.3 Microbiome Labs Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Microbiome Labs Psychobiotic Supplements Product Portfolio
  60. 8.10.5 Microbiome Labs Recent Developments
  61. 8.11 G1 NUTRITION
  62. 8.11.1 G1 NUTRITION Company Information
  63. 8.11.2 G1 NUTRITION Business Overview
  64. 8.11.3 G1 NUTRITION Psychobiotic Supplements Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 G1 NUTRITION Psychobiotic Supplements Product Portfolio
  66. 8.11.5 G1 NUTRITION Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Psychobiotic Supplements Value Chain Analysis
  2. 9.1.1 Psychobiotic Supplements Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Psychobiotic Supplements Production Mode & Process
  6. 9.2 Psychobiotic Supplements Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Psychobiotic Supplements Distributors
  9. 9.2.3 Psychobiotic Supplements Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst